Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials

This publication has 23 references indexed in Scilit:

• Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997–1998
  Journal of Antimicrobial Chemotherapy, 1999
• International Surveillance of Susceptibility to Levofloxacin and Other Agents among Respiratory Pathogens
  Drugs, 1999
• Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates ofStreptococcus pneumoniaein North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program
  Clinical Infectious Diseases, 1998
• Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season
  Diagnostic Microbiology and Infectious Disease, 1997
• The Continued Emergence of Drug-Resistant Streptococcus pneumoniae in the United States: An Update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System
  The Journal of Infectious Diseases, 1996
• A multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens in the United States, 1992–1994
  Diagnostic Microbiology and Infectious Disease, 1996
• Trends in infectious diseases mortality in the United States
  JAMA, 1996
• Community-Acquired Pneumonia
  New England Journal of Medicine, 1995
• In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993
  Antimicrobial Agents and Chemotherapy, 1994
• Antimicrobial Resistance of Streptococcus pneumoniae in the United States, 1979-1987
  The Journal of Infectious Diseases, 1991